Abstract is: Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program. Dana is an internationally recognized expert in the field of corneal disorders and ocular inflammation. He is best known for his work on the molecular and cellular mechanisms of ocular inflammation with translational applications to autoimmunity, transplantation, dry eye disease, and angiogenesis. He is a member of editorial boards of 10 journals, including as editor-in-chief of Cornea.
| human | Q5 |
| P646 | Freebase ID | /m/0xnx1mb |
| P1960 | Google Scholar author ID | g2QebxcAAAAJ |
| P213 | ISNI | 0000000384927008 |
| P8189 | National Library of Israel J9U ID | 987012500843305171 |
| P691 | NL CR AUT ID | mub20231181032 |
| P496 | ORCID iD | 0000-0002-5732-5100 |
| P214 | VIAF ID | 279174624 |
| P27 | country of citizenship | United States of America | Q30 |
| P69 | educated at | Harvard University | Q13371 |
| Johns Hopkins University | Q193727 | ||
| Johns Hopkins Bloomberg School of Public Health | Q858206 | ||
| Johns Hopkins School of Medicine | Q858729 | ||
| P108 | employer | Harvard University | Q13371 |
| P734 | family name | Dana | Q15073787 |
| Dana | Q15073787 | ||
| Dana | Q15073787 | ||
| P101 | field of work | medicine | Q11190 |
| immunology | Q101929 | ||
| eye inflammation | Q2971524 | ||
| eye disease | Q3041498 | ||
| P735 | given name | Reza | Q19832237 |
| Reza | Q19832237 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | university teacher | Q1622272 |
| ophthalmologist | Q12013238 | ||
| immunologist | Q12119633 | ||
| P21 | sex or gender | male | Q6581097 |
| Q37038747 | A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease |
| Q38818724 | A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease |
| Q34805624 | A novel function for programmed death ligand-1 regulation of angiogenesis |
| Q34936821 | A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. |
| Q33761001 | A novel murine model for keratoprosthesis |
| Q33567458 | A novel pro-angiogenic function for interferon-γ-secreting natural killer cells |
| Q35525349 | A novel pro-lymphangiogenic function for Th17/IL-17. |
| Q92344938 | A standardized methodology for longitudinal assessment of corneal endothelial morphometry in eye banked corneas |
| Q91914620 | Aged mice exhibit severe exacerbations of dry eye disease with an amplified memory Th17 cell response |
| Q38886086 | Ageing and ocular surface immunity. |
| Q57778788 | Alkali Burn to the Eye |
| Q38835393 | Alloimmunity and Tolerance in Corneal Transplantation |
| Q35589468 | Alteration of galectin-3 in tears of patients with dry eye disease |
| Q45930063 | Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. |
| Q28214408 | Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye |
| Q98155056 | Animal models of high-risk corneal transplantation: A comprehensive review |
| Q33437576 | Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators |
| Q89956016 | Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application |
| Q99560524 | Association of α-Melanocyte-Stimulating Hormone With Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor Tissue |
| Q95584039 | Authors' Response |
| Q37071969 | Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression |
| Q37278726 | Bilateral corneal ulceration in ocular graft-versus-host disease |
| Q36776787 | Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease |
| Q42171986 | CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue |
| Q34211406 | CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease |
| Q36185889 | Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study |
| Q36945904 | Change in prostaglandin expression levels and synthesizing activities in dry eye disease |
| Q91486780 | Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application |
| Q35220947 | Characterization of Langerin-expressing dendritic cell subsets in the normal cornea |
| Q34065949 | Characterization of effector T cells in dry eye disease |
| Q47601028 | Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities |
| Q30881344 | Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis |
| Q54602794 | Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. |
| Q98471726 | Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis |
| Q42804831 | Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium. |
| Q35798154 | Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye |
| Q28216792 | Complete androgen insensitivity syndrome: effect on human meibomian gland secretions |
| Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
| Q50057863 | Conjunctivochalasis: A Systematic Review. |
| Q37895402 | Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable |
| Q38260206 | Consensus statement on the immunohistochemical detection of ocular lymphatic vessels |
| Q31064303 | Construction of human corneal endothelial cDNA library and identification of novel active genes. |
| Q37413669 | Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands |
| Q47562176 | Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. |
| Q35833720 | Corneal Epithelial Immune Dendritic Cell Alterations in Subtypes of Dry Eye Disease: A Pilot In Vivo Confocal Microscopic Study |
| Q34881185 | Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity |
| Q42605451 | Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1 |
| Q50098128 | Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. |
| Q39620107 | Corneal endothelial cells are protected from apoptosis by gene therapy. |
| Q88679949 | Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD |
| Q34912568 | Corneal inflammation after miniature keratoprosthesis implantation |
| Q37080895 | Corneal innervation as a window to peripheral neuropathies |
| Q37479351 | Corneal lymphangiogenesis: implications in immunity. |
| Q26823757 | Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin) |
| Q39589760 | Corneal penetration of topical and subconjunctival bevacizumab |
| Q34172867 | Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. |
| Q89284300 | Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150] |
| Q104131893 | Defining Dry Eye from a Clinical Perspective |
| Q37940579 | Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis |
| Q42059287 | Dependence of corneal stem/progenitor cells on ocular surface innervation |
| Q41786670 | Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival? |
| Q93076558 | Descemet Membrane Endothelial Keratoplasty Failure Associated with Innate Immune Activation |
| Q40192535 | Determinants of Ocular Pain Severity in Patients With Dry Eye Disease |
| Q79657699 | Development and validation of a short global dry eye symptom index |
| Q85720524 | Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells |
| Q35865098 | Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q39289870 | E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation |
| Q36791071 | Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye |
| Q28141302 | Effect of androgen deficiency on the human meibomian gland and ocular surface |
| Q36758312 | Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis |
| Q35684022 | Effect of topical azithromycin on corneal innate immune responses |
| Q35214116 | Effects of corneal nerve density on the response to treatment in dry eye disease |
| Q51175859 | Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. |
| Q33845555 | Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival |
| Q98185588 | Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease |
| Q98626684 | Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis |
| Q36044544 | Efficacy of topical blockade of interleukin-1 in experimental dry eye disease |
| Q89498370 | Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients |
| Q91354085 | Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System |
| Q41070931 | Evaluating Changes in Ocular Redness Using a Novel Automated Method |
| Q47326004 | Evaluating Corneal Fluorescein Staining Using a Novel Automated Method |
| Q34952967 | Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? |
| Q37401529 | Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection |
| Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
| Q50459535 | Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. |
| Q50162469 | Factors Influencing the Diagnostic Accuracy of Laser-Scanning In Vivo Confocal Microscopy for Acanthamoeba Keratitis. |
| Q35030948 | Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway |
| Q42416785 | Gamma-irradiation reduces the allogenicity of donor corneas |
| Q90918395 | Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency |
| Q97434381 | Global Consensus on the Management of Limbal Stem Cell Deficiency |
| Q37219269 | Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling |
| Q36761972 | Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis |
| Q33208055 | Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue. |
| Q37363012 | Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future |
| Q104789750 | Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application |
| Q34076208 | High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen |
| Q48240995 | IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. |
| Q42737501 | IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity |
| Q92212259 | Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study |
| Q35741609 | Impact of dry eye syndrome on vision-related quality of life |
| Q37529334 | Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection |
| Q36126638 | In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease |
| Q38603719 | In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation |
| Q33861196 | Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis |
| Q89062976 | Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update |
| Q35001933 | Interferon-γ-secreting NK cells promote induction of dry eye disease |
| Q92582667 | Interleukin-6 neutralization prolongs corneal allograft survival |
| Q48920345 | Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. |
| Q37365681 | International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). |
| Q35672575 | Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease |
| Q36679476 | In Vivo confocal microscopic changes of the corneal epithelium and stroma in patients with herpes zoster ophthalmicus |
| Q28189953 | Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? |
| Q92358387 | Keratoconus progression associated with hormone replacement therapy |
| Q50968165 | Kinetics of Angiogenic Responses in Corneal Transplantation. |
| Q89928664 | Kinetics of Corneal Antigen Presenting Cells in Experimental Dry Eye Disease |
| Q33196408 | Laser cataract surgery: past, present, and evolving technologies. |
| Q42042533 | Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation |
| Q100427375 | Limbal Stem Cell Deficiency Associated With Herpes Keratitis |
| Q91885039 | Limbal and Conjunctival Epithelial Thickness in Ocular Graft-Versus-Host Disease |
| Q91681739 | Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival |
| Q95936274 | Long-term Outcome of Punctal Cauterization in the Management of Ocular Surface Diseases |
| Q91329161 | Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases |
| Q38778422 | Management of High-risk Corneal Transplantation |
| Q93169440 | Management of meibomian gland dysfunction: a review |
| Q51056510 | Mechanisms of Retinal Damage after Ocular Alkali Burns. |
| Q30886241 | Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation |
| Q90156371 | Medical and surgical management of conjunctivochalasis |
| Q56692326 | Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome |
| Q92678975 | Methods for Assessing Corneal Opacity |
| Q57778725 | Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries |
| Q64889398 | Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries. |
| Q46209348 | Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease |
| Q36581261 | Nerves and neovessels inhibit each other in the cornea. |
| Q91026766 | Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation |
| Q38868323 | Neuropeptide substance P and the immune response |
| Q34984061 | Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision |
| Q38955064 | Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells |
| Q34116123 | Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. |
| Q38904210 | Ocular Manifestations of Inherited Phospholipase-Cγ2-Associated Antibody Deficiency and Immune Dysregulation |
| Q91252182 | Ocular adhesives: Design, chemistry, crosslinking mechanisms, and applications |
| Q38094336 | Ocular graft-versus-host disease: a review |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q27348742 | Ocular surgical models for immune and angiogenic responses. |
| Q35054413 | Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation |
| Q36142214 | Optimising keratoplasty for Peters' anomaly in infants using spectral-domain optical coherence tomography |
| Q92850038 | Oral guaifenesin for treatment of filamentary keratitis: A pilot study |
| Q92324991 | Outcomes of Cyanoacrylate Tissue Adhesive Application in Corneal Thinning and Perforation |
| Q35661048 | Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease |
| Q35852464 | Overestimation of Corneal Endothelial Cell Density in Smaller Frame Sizes in In Vivo Confocal Microscopy |
| Q36122993 | PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease |
| Q35789092 | PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1. |
| Q55064864 | Pathological conversion of regulatory T cells is associated with loss of allotolerance. |
| Q62116774 | Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium |
| Q36242214 | Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss |
| Q40210892 | Patients' Perceived Treatment Effectiveness in Dry Eye Disease |
| Q39617479 | Patients' Perspectives on Their Dry Eye Disease |
| Q59805214 | Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes |
| Q57778739 | Permanent neuroglial remodeling of the retina following infiltration of CSF1R-inhibition resistant peripheral monocytes |
| Q94590279 | Pigment Epithelium-derived factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease |
| Q99569913 | Prevalence and Risk Factors Associated With Corneal Perforation in Chronic Ocular Graft-Versus-Host-Disease |
| Q97895218 | Prevalence of PersistentCorneal Epithelial Defects in Chronic Ocular Graft- Versus-Host Disease |
| Q33720070 | Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies |
| Q28196875 | Prevalence of dry eye syndrome among US women |
| Q36829097 | Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease |
| Q38753891 | Proangiogenic Function of T Cells in Corneal Transplantation. |
| Q36287795 | Radiotherapy-induced ocular surface disease |
| Q35579883 | Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease |
| Q88151824 | Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease |
| Q37691860 | Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation |
| Q37242034 | Regulation of blood vessel versus lymphatic vessel growth in the cornea |
| Q101475417 | Regulatory T Cells in Angiogenesis |
| Q91740503 | Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection |
| Q90518726 | Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10 |
| Q37940582 | Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis |
| Q24537414 | Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women |
| Q95376152 | Reply |
| Q42391035 | Reply: To PMID 22967868. |
| Q96030375 | Restoration of regulatory T cell function in dry eye disease by antagonizing substance P/neurokinin-1 receptor |
| Q64265163 | Retinal microglia initiate neuroinflammation in ocular autoimmunity |
| Q90501872 | Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm |
| Q33845377 | Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation |
| Q36571709 | Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. |
| Q42371417 | Scaling and maintenance of corneal thickness during aging. |
| Q38818437 | Sensitivity and Specificity of Laser-Scanning In Vivo Confocal Microscopy for Filamentous Fungal Keratitis: Role of Observer Experience |
| Q29999764 | Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization |
| Q34459026 | Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival |
| Q96690980 | Stratification of Individual Symptoms of Contact Lens-Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study |
| Q87965743 | Subtarsal Fibrosis Is Associated With Ocular Surface Epitheliopathy in Graft-Versus-Host Disease |
| Q42683229 | Sufficient Evidence for Lymphatics in the Developing and Adult Human Choroid? |
| Q64072768 | Sutureless repair of corneal injuries using naturally derived bioadhesive hydrogels |
| Q38904800 | Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation |
| Q37686712 | T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration |
| Q39453364 | TFOS DEWS II Management and Therapy Report |
| Q36926074 | The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease |
| Q37037763 | The Ocular Redness Index: a novel automated method for measuring ocular injection |
| Q57778734 | The Role of Microglia and Peripheral Monocytes in Retinal Damage after Corneal Chemical Injury |
| Q34173660 | The corneal stroma is endowed with a significant number of resident dendritic cells |
| Q37761089 | The culture and transplantation of human limbal stem cells. |
| Q39347374 | The function of regulatory T cells at the ocular surface: Review. |
| Q93196098 | The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease |
| Q90586597 | The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease |
| Q34769324 | The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee |
| Q64938051 | The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection. |
| Q34230865 | The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation |
| Q96018188 | The role of Th17 immunity in chronic ocular surface disorders |
| Q87444199 | The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials |
| Q50147046 | Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation. |
| Q36989668 | Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. |
| Q34973731 | Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes |
| Q34953282 | Thrombospondin-1 derived from APCs regulates their capacity for allosensitization |
| Q92586779 | Thrombospondin-1 in ocular surface health and disease |
| Q90492376 | Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial |
| Q37244781 | Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. |
| Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
| Q37577521 | Topical ranibizumab as a treatment of corneal neovascularization |
| Q41244028 | Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency |
| Q38827673 | Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation. |
| Q36911922 | Trigeminal stereotactic electrolysis induces dry eye in mice |
| Q55068558 | VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. |
| Q79826261 | Validation and repeatability of a short questionnaire for dry eye syndrome |
| Q33909046 | Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain. |
| Q35921437 | Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis |
| Q90877081 | Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival |
| Q35894005 | Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease |
| Q50152379 | Web-based longitudinal remote assessment of dry eye symptoms. |
| Q37397203 | What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? |
| Q47297420 | When Clarity Is Crucial: Regulating Ocular Surface Immunity |
| Q36892952 | b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern |
| Reza Dana | wikipedia |
Search more.